abstract |
The present invention provides compositions and methods for treating cancer characterized by the loss of Pten, Zbtb7a / Pokemon, p53, Pml and other tumor suppressors by inhibiting the expression or activity of CXCL5, and a mouse platform. Features a method for using to identify therapeutic agents. |